Atelectasis is a medical condition in which the lungs collapse, resulting in difficulty breathing. It is a serious condition that can be life-threatening if left untreated. In this article, we will take a closer look at atelectasis, including its causes, symptoms, diagnosis, and treatment options.
Atelectasis is a medical condition in which the air sacs in the lungs collapse, resulting in difficulty breathing. It can be caused by a variety of factors, including blockage of the airways, a decrease in the amount of air being inhaled, or a decrease in the amount of air being exhaled. Atelectasis can be classified into two types: obstructive and non-obstructive. Obstructive atelectasis is caused by a blockage in the airways, such as a tumor or foreign object. Non-obstructive atelectasis is caused by a decrease in the amount of air being inhaled or exhaled.
Atelectasis can be caused by a variety of factors, including blockage of the airways, a decrease in the amount of air being inhaled, or a decrease in the amount of air being exhaled. Common causes of obstructive atelectasis include tumors, foreign objects, mucus plugs, and scarring from previous lung infections. Non-obstructive atelectasis is often caused by a decrease in the amount of air being inhaled or exhaled. This can be caused by a decrease in lung volume due to surgery, trauma, or illness. It can also be caused by a decrease in the amount of air being exhaled due to a decrease in the amount of oxygen in the air, such as at high altitudes.
The symptoms of atelectasis can vary depending on the cause and severity of the condition. Common symptoms include shortness of breath, chest pain, coughing, wheezing, and fatigue. Other symptoms can include fever, rapid breathing, and cyanosis (a bluish discoloration of the skin caused by a lack of oxygen in the blood).
Atelectasis is usually diagnosed with a physical exam, chest X-ray, or CT scan. During the physical exam, the doctor will listen to the lungs with a stethoscope to detect any changes in the sounds of the lungs. A chest X-ray or CT scan can help the doctor detect any changes in the size or shape of the lungs.
The treatment of atelectasis depends on the cause and severity of the condition. In most cases, treatment involves clearing the airway obstruction and restoring normal breathing. This can be done with medications, bronchoscopy (a procedure to remove foreign objects or mucus plugs), or surgery. In some cases, oxygen therapy may be necessary to help the patient breathe more easily.
Atelectasis is a serious medical condition in which the lungs collapse, resulting in difficulty breathing. It can be caused by a variety of factors, including blockage of the airways, a decrease in the amount of air being inhaled, or a decrease in the amount of air being exhaled. The symptoms of atelectasis can vary depending on the cause and severity of the condition. It is usually diagnosed with a physical exam, chest X-ray, or CT scan. Treatment of atelectasis depends on the cause and severity of the condition and can include medications, bronchoscopy, surgery, or oxygen therapy.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation